Purdue Drug Discovery Training Program
Purdue Drug Discovery Training Program
批准号:
10186773
负责人:
Mingji Dai
金额:
$19.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-06-30
中文摘要
摘要
普渡大学药物发现培训计划(PDD-TP)的目标是提供
博士前学生与药物发现的全面和平衡的观点,
开发,并开发多学科的方法来设计新的分子
具有有前景的药用活性的实体,随后进行优化和临床前研究
评价学员将参加一个综合课程,扩大他们的知识广度
和实验方法,以发现新的药物开发目标,并将
在他们的主要实验室之外参加一个研究嵌入项目,
经验和培训。受训人员还将参加具体方案的活动,
加强沟通,批判性思维,领导力,管理,指导,网络,
和反犹太主义。活动包括期刊俱乐部,跨学科的正式介绍,
研究,组织药物发现研讨会,吸引专家参与的独特机会,
评估药品管道候选人,并参加模拟药品小组审查。每
将努力最大限度地扩大培训计划申请者的多样性,并招募和
留住不同背景的学员。PDD-TP学员毕业时将获得全面的
技能和接触药物发现和管道开发,并具有
将在他们进入生物医学劳动力市场后很长一段时间内继续为他们服务。
英文摘要
Abstract
The objective of the Purdue Drug Discovery Training Program (PDD-TP) is to provide
predoctoral students with a comprehensive and balanced perspective of drug discovery and
development, and to develop a multi-disciplinary approach toward the design of novel molecular
entities with promising medicinal activity, with subsequent optimization and preclinical
evaluation. Trainees will take an integrated curriculum that expands their breadth of knowledge
and experimental approach toward the discovery of novel targets for drug development, and will
participate in a research embedding project outside their primary laboratory for further
experience and training. Trainees will also participate in program-specific activities intended to
enhance communication, critical thinking, leadership, management, mentorship, networking,
and entrepreneurism. Activities include a journal club, formal presentations of cross-disciplinary
research, organization of seminars in drug discovery, unique opportunities to engage experts in
the evaluation of drug pipeline candidates, and participation in a mock drug panel review. Every
effort will be made to maximize the diversity of training program applicants, and to recruit and
retain trainees of diverse backgrounds. PDD-TP trainees will graduate with a comprehensive
skill set and exposure to drug discovery and pipeline development, and with experiences that
will continue to serve them long after they enter the biomedical workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthesis and Study of Medicinally Important Molecules
-
批准号:10216307
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2018
-
负责人:Mingji Dai
-
依托单位:
Synthesis and Study of Medicinally Important Molecules
-
批准号:10459633
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Mingji Dai
-
依托单位:
Synthesis and Study of Medicinally Important Molecule
-
批准号:10685687
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2018
-
负责人:Mingji Dai
-
依托单位:
Synthesis and Study of Medicinally Important Molecules
-
批准号:9755457
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2018
-
负责人:Mingji Dai
-
依托单位:
Synthesis and Study of Medicinally Important Molecules
-
批准号:10620871
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2018
-
负责人:Mingji Dai
-
依托单位:
Targets, Structures and Drugs (TSD)
-
批准号:10658897
-
项目类别:
-
资助金额:$4.23万
-
财政年份:1998
-
负责人:Mingji Dai
-
依托单位:
Targets, Structures and Drugs (TSD)
-
批准号:10434761
-
项目类别:
-
资助金额:$4.23万
-
财政年份:1998
-
负责人:Mingji Dai
-
依托单位:
Targets, Structures and Drugs (TSD)
-
批准号:10223207
-
项目类别:
-
资助金额:$4.23万
-
财政年份:1998
-
负责人:Mingji Dai
-
依托单位:
海外基金